Acadia Pharmaceuticals reported $624.25M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 624.25M 75.87M
ALKERMES ALKS:US $ 1977.84M 46.64M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Aptinyx Inc APTX:US $ 106.65M 8.27M
Biogen BIIB:US $ 23614.4M 262.9M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Cara Therapeutics CARA:US $ 223.87M 23.19M
Corcept Therapeutics CORT:US $ 468.12M 44.37M
Cytokinetics CYTK:US $ 856.25M 14.93M
Eisai 4523:JP Y 1239315M 71959M
Eli Lilly And LLY:US $ 46919.3M 1886.7M
Intercept Pharmaceuticals ICPT:US $ 503.36M 23.67M
Intra Cellular Therapies ITCI:US $ 868.58M 378.66M
Johnson & Johnson JNJ:US $ 178355M 3663M
Marinus Pharmaceuticals MRNS:US $ 140.81M 3.97M
Moderna Inc MRNA:US 27.61B 2.94B
Prothena PRTA:US $ 581.41M 27.95M
Ptc Therapeutics PTCT:US $ 1799.59M 138.46M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
Ultragenyx Pharmaceutical RARE:US $ 1384.03M 138.37M
Vanda Pharmaceuticals VNDA:US $ 603.56M 9.77M
Vertex Pharmaceuticals VRTX:US $ 14256.1M 823.6M
YTE INCY:US $ 5054.22M 120.87M